John P. de Koning

1.0k total citations
15 papers, 842 citations indexed

About

John P. de Koning is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, John P. de Koning has authored 15 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in John P. de Koning's work include Blood disorders and treatments (6 papers), Immune Response and Inflammation (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). John P. de Koning is often cited by papers focused on Blood disorders and treatments (6 papers), Immune Response and Inflammation (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). John P. de Koning collaborates with scholars based in Netherlands, United States and Poland. John P. de Koning's co-authors include Ivo P. Touw, Alister C. Ward, Jian‐Hua Mao, Allan Balmain, Hiroki Nagase, Daphne van Leeuwen, Anita M. Schelen, Louise Smith, Bob Löwenberg and Paraskevi Briassouli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

John P. de Koning

15 papers receiving 832 citations

Peers

Countries citing papers authored by John P. de Koning

Since Specialization

Citations

This map shows the geographic impact of John P. de Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. de Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. de Koning more than expected).

Fields of papers citing papers by John P. de Koning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. de Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. de Koning. The network helps show where John P. de Koning may publish in the future.

Co-authorship network of co-authors of John P. de Koning

This figure shows the co-authorship network connecting the top 25 collaborators of John P. de Koning. A scholar is included among the top collaborators of John P. de Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. de Koning. John P. de Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Convergence of congenic mapping and allele-specific alterations in tumors for the resolution of the Skts1 skin tumor susceptibility locus 2007 ·Oncogene ·John P. de Koning, Yuichi Wakabayashi, Hiroki Nagase, Jian‐Hua Mao, Allan Balmain	12
2	Genetic variants ofTgfb1act as context-dependent modifiers of mouse skin tumor susceptibility 2006 ·Proceedings of the National Academy of Sciences ·Jian‐Hua Mao, Elise F. Saunier, John P. de Koning, Margaret L. McKinnon, (unknown), (unknown), Haitao Yang, Allan Balmain, Rosemary J. Akhurst	32
3	Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human 2003 ·Nature Genetics ·Amanda E. Toland, Paraskevi Briassouli, John P. de Koning, Jian‐Hua Mao, Jinwei Yuan, Florence Chan, Lucy MacCarthy‐Morrogh, Bruce A.J. Ponder, Hiroki Nagase, John Burn, Sarah Ball, Maria Rosário Almeida, Spiros Linardopoulos, Allan Balmain	267
4	Novel Approaches to Identify Low-Penetrance Cancer Susceptibility Genes Using Mouse Models 2003 ·Recent results in cancer research ·John P. de Koning, Jian‐Hua Mao, Allan Balmain	4
5	Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice. 2001 ·PubMed ·Hiroki Nagase, Jian‐Hua Mao, John P. de Koning, (unknown), Allan Balmain	47
6	STAT3β does not interfere with granulocyte colony-stimulating factor-induced neutrophilic differentiation 2000 ·The Hematology Journal ·John P. de Koning, Alister C. Ward, Eric Caldenhoven, Rolf P. de Groot, Bob Löwenberg, Ivo P. Touw	7
7	STAT3-mediated differentiation and survival of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27Kip1 2000 ·Oncogene ·John P. de Koning, (unknown), Alister C. Ward, Anita M. Schelen, (unknown), Daphne van Leeuwen, Bob Löwenberg, Ivo P. Touw	112
8	Signaling mechanisms of cytokine receptors and their perturbances in disease 2000 ·Molecular and Cellular Endocrinology ·Ivo P. Touw, John P. de Koning, Alister C. Ward, Mirjam H. A. Hermans	39
9	Multiple Signals Mediate Proliferation, Differentiation, and Survival from the Granulocyte Colony-stimulating Factor Receptor in Myeloid 32D Cells 1999 ·Journal of Biological Chemistry ·Alister C. Ward, Louise Smith, John P. de Koning, (unknown), Ivo P. Touw	105
10	Novel Point Mutation in the Extracellular Domain of the Granulocyte Colony-Stimulating Factor (G-Csf) Receptor in a Case of Severe Congenital Neutropenia Hyporesponsive to G-Csf Treatment 1999 ·The Journal of Experimental Medicine ·Alister C. Ward, (unknown), Judith Gits, Anita M. Schelen, John P. de Koning, Daphne van Leeuwen, Melvin H. Freedman, Ivo P. Touw	68
11	Stimulation of Stat5 by Granulocyte Colony-Stimulating Factor (G-CSF) Is Modulated by Two Distinct Cytoplasmic Regions of the G-CSF Receptor 1998 ·The Journal of Immunology ·Fan Dong, Xiuwen Liu, John P. de Koning, Ivo P. Touw, (unknown), Andrew C. Larner, Philip M. Grimley	78
12	Proliferation Signaling and Activation of Shc, p21Ras, and Myc Via Tyrosine 764 of Human Granulocyte Colony-Stimulating Factor Receptor 1998 ·Blood ·John P. de Koning, (unknown), Anita M. Schelen, Louise Smith, Daphne van Leeuwen, Valeria Santini, Boudewijn Burgering, Johannes L. Bos, Bob Löwenberg, Ivo P. Touw	55
13	Proliferation Signaling and Activation of Shc, p21Ras, and Myc Via Tyrosine 764 of Human Granulocyte Colony-Stimulating Factor Receptor 1998 ·Blood ·John P. de Koning, (unknown), Anita M. Schelen, Louise Smith, Daphne van Leeuwen, Valeria Santini, Boudewijn Burgering, Johannes L. Bos, Bob Löwenberg, Ivo P. Touw	4
14	Advances in understanding the biology and function of the G-CSF receptor 1996 ·Current Opinion in Hematology ·John P. de Koning, Ivo P. Touw	10
15	Identification of Functional Domains of Interleukin-3 by Construction of Primate Interspecies Chimera 1994 ·Growth Factors ·Lambert C. J. Dorssers, Herman Burger, Gerard Wagemaker, John P. de Koning	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact